Sales
€5.7 billion
2023: €6.4 billion
Sales by region
-
Europe
39%
-
Asia
37%
-
The Americas
18%
-
Other regions
6%
Sales by business division
-
Silicones
€2,805 million
-
Polymers
€1,463 million
-
Biosolutions
€375 million
-
Polysilicon
€949 million
EBITDA
€763 million
2023: €824 million
Employees
16,637
2023: 16,378
Capital expenditures
€666 million
2023: €710 million
Absolute greenhouse gas emissions (Scopes 1 and 2)
2024
2.5 in million metric tons
2023
2.8 in million metric tons
€ million |
|
December 31, 2024 |
|
December 31, 2023 |
|
Change |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|||||||||||||||
Results/return |
|
|
|
|
|
|
|||||||||||||||
Sales |
|
5,721.8 |
|
6,402.2 |
|
-10.6 |
|||||||||||||||
EBITDA1 |
|
762.8 |
|
823.6 |
|
-7.4 |
|||||||||||||||
EBITDA margin2 (%) |
|
13.3 |
|
12.9 |
|
n.a. |
|||||||||||||||
EBIT3 |
|
290.1 |
|
404.9 |
|
-28.4 |
|||||||||||||||
EBIT margin2 (%) |
|
5.1 |
|
6.3 |
|
n.a. |
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
Financial result |
|
-31.7 |
|
-17.9 |
|
77.1 |
|||||||||||||||
Income before income taxes |
|
258.4 |
|
387.0 |
|
-33.2 |
|||||||||||||||
Net result for the year |
|
260.7 |
|
327.3 |
|
-20.3 |
|||||||||||||||
Earnings per share (basic/diluted) (€) |
|
4.85 |
|
6.31 |
|
-23.1 |
|||||||||||||||
ROCE (%) |
|
5.0 |
|
6.9 |
|
-27.5 |
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
Financial position/cash flow |
|
|
|
|
|
|
|||||||||||||||
Total assets |
|
9,409.9 |
|
8,854.4 |
|
6.3 |
|||||||||||||||
Equity |
|
4,837.0 |
|
4,579.9 |
|
5.6 |
|||||||||||||||
Equity ratio (%) |
|
51.4 |
|
51.7 |
|
n.a. |
|||||||||||||||
Liquidity4 |
|
1,256.1 |
|
1,421.9 |
|
-11.7 |
|||||||||||||||
Financing liabilities |
|
1,946.7 |
|
1,505.6 |
|
29.3 |
|||||||||||||||
Net financial debt5 |
|
-690.6 |
|
-83.7 |
|
>100 |
|||||||||||||||
Capital expenditures6 |
|
666.0 |
|
709.6 |
|
-6.1 |
|||||||||||||||
Depreciation/amortization |
|
-472.7 |
|
-418.7 |
|
12.9 |
|||||||||||||||
Net cash flow7 |
|
-326.0 |
|
165.6 |
|
n.a. |
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
Research and development |
|
|
|
|
|
|
|||||||||||||||
Research and development expenses |
|
203.7 |
|
184.1 |
|
10.6 |
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
Employees |
|
|
|
|
|
|
|||||||||||||||
Personnel expenses |
|
1,579.8 |
|
1,479.6 |
|
6.8 |
|||||||||||||||
Employees (number as of Dec. 31) |
|
16,637 |
|
16,378 |
|
1.6 |
|||||||||||||||
|
|||||||||||||||||||||
